Elisabeth Emilsen
- Co-authors
- Viví Ann FlørenesAna SlipicevicAnne Katrine Ree RosnesRuth HolmBen DavidsonAasmund BernerBjørn RisbergØystein Fodstad
- Topics
- Melanoma and MAPK Pathways (3 papers)Cell death mechanisms and regulation (3 papers)interferon and immune responses (2 papers)
- Partner nations
- NorwayUnited StatesIsrael
In The Last Decade
Elisabeth Emilsen
16 papers receiving 421 citations
Peers
Comparison fields: 5 of 63
- Molecular Biology 280
- Oncology 167
- Cancer Research 80
- Pulmonary and Respiratory Medicine 60
- Immunology 60
Countries citing papers authored by Elisabeth Emilsen
This map shows the geographic impact of Elisabeth Emilsen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elisabeth Emilsen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elisabeth Emilsen more than expected).
Fields of papers citing papers by Elisabeth Emilsen
This network shows the impact of papers produced by Elisabeth Emilsen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elisabeth Emilsen. The network helps show where Elisabeth Emilsen may publish in the future.
Co-authorship network of co-authors of Elisabeth Emilsen
This figure shows the co-authorship network connecting the top 25 collaborators of Elisabeth Emilsen. A scholar is included among the top collaborators of Elisabeth Emilsen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elisabeth Emilsen. Elisabeth Emilsen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 10 | |
| 2 | 8 | |
| 3 | 40 | |
| 4 | 8 | |
| 5 | 14 | |
| 6 | 0 | |
| 7 | 25 | |
| 8 | 122 | |
| 9 | 1 | |
| 10 | 26 | |
| 11 | 5 | |
| 12 | 25 | |
| 13 | 18 | |
| 14 | 6 | |
| 15 | 91 | |
| 16 | 26 | |
| 17 | 3 |
About Elisabeth Emilsen
Elisabeth Emilsen is a scholar working on Molecular Biology, Cancer Research and Immunology, having authored 17 papers that have together received 428 indexed citations. Recurring topics across this work include Melanoma and MAPK Pathways (3 papers), Cell death mechanisms and regulation (3 papers) and interferon and immune responses (2 papers). The work is most often cited by research in Oncology (167 citations), Cancer Research (80 citations) and Molecular Biology (280 citations). Elisabeth Emilsen has collaborated with scholars based in Norway, United States and Israel. Frequent co-authors include Viví Ann Flørenes, Ana Slipicevic, Anne Katrine Ree Rosnes, Ruth Holm, Ben Davidson, Aasmund Berner, Bjørn Risberg, Øystein Fodstad, Gunnar Kvalheim and Gunnar B. Kristensen. Their work appears in journals such as PLoS ONE, Biochemical and Biophysical Research Communications and International Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.